Australia markets open in 7 hours 20 minutes

Cadrenal Therapeutics, Inc. (CVKD)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4305+0.0069 (+1.63%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
Total revenue
0
0
Operating expenses
Research development
4,081
4,081
Selling general and administrative
3,550
3,550
Total operating expenses
7,633
7,633
Operating income or loss
-7,633
-7,633
Interest expense
17.101
17.101
Total other income/expenses net
-956.234
-956.234
Income before tax
-8,357
-8,357
Income from continuing operations
-8,357
-8,357
Net income
-8,357
-8,357
Net income available to common shareholders
-8,357
-8,357
Basic EPS
-0.62
-
Diluted EPS
-0.62
-
Basic average shares
13,023
-
Diluted average shares
13,023
-